Randomized Evaluation of Maxillary Antrostomy Versus Ostial Dilation Efficacy Through Long-Term Follow-Up
- Conditions
- Chronic Sinusitis
- Interventions
- Device: Balloon Sinus DilationProcedure: Functional Endoscopic Sinus Surgery
- Registration Number
- NCT01525849
- Lead Sponsor
- Entellus Medical, Inc.
- Brief Summary
The objective of this study is to show that long-term symptom improvement after sinus balloon dilation is not worse than symptom improvement after functional endoscopic sinus surgery (FESS) and that fewer postoperative debridements are required after balloon dilation than after FESS.
- Detailed Description
This is a postmarket, multicenter, prospective, randomized clinical trial conducted at up to 15 US clinical sites comparing the efficacy of balloon sinus dilation with traditional endoscopic sinus surgery. The primary hypotheses were to demonstrate that: 1) long-term change in sinus symptoms after balloon dilation is not worse (non-inferior) than after FESS, and 2) balloon dilation is superior to FESS for a reduction in the number of postoperative debridements per patient. A minimum of 36 participants per arm is required to test the primary hypotheses. All participants will be followed through a minimum of 12 months post treatment.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 151
- 18 years or older
- maxillary sinus disease
- chronic sinusitis
- fungal disease
- Samter's triad
- hemophilia
- prior sinus surgery
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Balloon Sinus Dilation Balloon Sinus Dilation XprESS Multi-Sinus Dilation Balloon, FinESS Sinus Treatment Functional Endoscopic Sinus Surgery Functional Endoscopic Sinus Surgery Traditional endoscopic sinus surgery (maxillary antrostomy and uncinectomy with optional anterior ethmoidectomy) using cutting, grasping, and microdebrider tools.
- Primary Outcome Measures
Name Time Method Sinus Symptom Improvement Baseline and 1-year Change from baseline in overall 20-item Sino-Nasal Outcome Test (SNOT-20) score. The SNOT-20 is a validated patient reported survey of 20 items related to sinonasal symptoms and severity assessed over the previous 2 weeks. Each item is scored from 0 (no problem) to 5 (problem as bad as it can be). The individual item scores are averaged to provide and overall score that ranges from 0 (best) to 5 (worst).
Debridements 1-year Number of postoperative debridements per participant
- Secondary Outcome Measures
Name Time Method Revision Rate 1-year Number of participants requiring repeat sinus procedures
Recovery Time 6-months Mean time (days) after procedure for participants to return to normal activities
Complication Rate Duration of study (minimum of 12 months) Number of participants experiencing 1 or more serious adverse events related to the device and/or procedure
Trial Locations
- Locations (1)
Entellus Medical
🇺🇸Plymouth, Minnesota, United States